Correction to “ HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression”EriksenDO, KrogL, OstenfeldEB, et al. HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression. Acta Obstet Gynecol Scand. 2026;105(2):377–385. doi:10.1111/aogs.70128.

Bibliographic Details
Main Author:	Dina Overgaard Eriksen
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Acta Obstetricia et Gynecologica Scandinavica
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression
by: Dina O. Eriksen, et al.
Published: (2026)

HPV vaccination coverage rate in women undergoing conization for cervical intraepithelial neoplasia in Spain: The COVAR study
by: Aureli Torné Blade, et al.
Published: (2025)

Genotype, cervical intraepithelial neoplasia, and type‐specific cervical intraepithelial neoplasia distributions in hrHPV+ cases referred to colposcopy: A multicenter study of Chinese mainland women
by: Mingyang Chen, et al.
Published: (2024)

Time trends in the clinical management of cervical intraepithelial neoplasia grade 2: A Danish register‐based study
by: Dina Overgaard Eriksen, et al.
Published: (2024)

Short-term risk of cervical intraepithelial neoplasia grades 2 and 3 for women with normal cytology and human papillomavirus infection
by: Gustavo Hernández-Suárez
Published: (2010)

From primary HPV infection to carcinoma in situ: a mathematical approach of cervical intraepithelial neoplasia
by: Bitsouni, Vasiliki, et al.
Published: (2024)

From primary HPV infection to carcinoma in situ: A mathematical approach to cervical intraepithelial neoplasia
by: Vasiliki Bitsouni, et al.
Published: (2024)

p16INK4a and HPV E4 immunohistochemistry for the prediction of regression of cervical intraepithelial neoplasia grade 2—A historical cohort study
by: Rikke Damgaard, et al.
Published: (2025)

Exposure to polycyclic aromatic hydrocarbons promotes the progression of low‐grade cervical intraepithelial neoplasia: A population‐based cohort study in China
by: Meng Cui, et al.
Published: (2024)

Generating a consensus on the follow‐up of multifocal high‐grade prostate intraepithelial neoplasia
by: Charles Carey, et al.
Published: (2026)

Distribution and diagnostic value of single and multiple high‐risk HPV infections in detection of cervical intraepithelial neoplasia: A retrospective multicenter study in China
by: Zichen Ye, et al.
Published: (2024)

Long‐term prediction by DNA methylation of high‐grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort
by: Clare Gilham, et al.
Published: (2024)

Diagnostic performance of human papillomavirus DNA cycle threshold values in the detection of high‐grade cervical intraepithelial neoplasia
by: Pattharapa Watcharasin, et al.
Published: (2026)

DNA methylation and copy number alterations in the progression of HPV‐associated high‐grade vulvar intraepithelial lesion
by: Flavia Runello, et al.
Published: (2025)

Spatial analysis of HPV ‐associated cervical intraepithelial neoplastic tissues demonstrate distinct immune signatures associated with cervical cancer progression
by: Gianna Pavilion, et al.
Published: (2025)

Predictive biomarkers for regression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2: A prospective multicenter study in Italy
by: Helena Frayle, et al.
Published: (2025)

Efficacy and safety of 5‐aminolevulinic acid‐based photodynamic therapy for cervical low‐grade squamous intraepithelial lesions with HPV infections
by: Yuan Hu, et al.
Published: (2025)

Enhanced diagnostic accuracy of high‐grade cervical intraepithelial neoplasia in postmenopausal women through PAX1 / JAM3 methylation analysis
by: Huanzi Peng, et al.
Published: (2025)

Cervical intraepithelial neoplasia progression and regression among women living with HIV in Zambia
by: John Andoh, et al.
Published: (2025)

Small cell neuroendocrine carcinoma with adenocarcinoma and high grade squamous intraepithelial neoplasia of the cervix
by: Guralarasan Gurubalan
Published: (2023)

Human papillomavirus genotyping in high‐grade vaginal intraepithelial neoplasia: A multicentric Italian study
by: Mario Preti, et al.
Published: (2024)

Discontinuation of cervical cancer screening for HPV‐vaccinated women?
by: Jesper Bonde, et al.
Published: (2024)

Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia
by: Katsushige Kawase, et al.
Published: (2024)

Human Papilloma Virus genotypes in Type III cervical intraepithelial neoplasia. Cuenca-Ecuador, 2013-2017
by: Patricio Santiago Tigre-Sinchi
Published: (2019)

Realising the promise of HPV vaccination – data from the national cervical screening and vaccination registers demonstrates the impact of HPV vaccination in Aotearoa New Zealand
by: Peter Sykes, et al.
Published: (2025)

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high‐grade squamous intraepithelial lesions ( VIVA trial): A randomized, double‐blind, placebo‐controlled trial
by: Helen C. Stankiewicz Karita, et al.
Published: (2026)

Synchronous eyelid oncocytoma and conjunctival intraepithelial neoplasia
by: Zachariah Chowdhury
Published: (2021)

Interaction between the level of human papillomavirus integration and human papillomavirus type on the risk of grade 3 cervical intraepithelial neoplasia or more severe in human papillomavirus integration positive women: A cross‐sectional study
by: Xin Liu, et al.
Published: (2025)

Epidemiological approaches to evaluate clinical unmasking of HPV ‐associated cervical lesions in the HPV vaccination era
by: Joseph E. Tota, et al.
Published: (2025)

The association between human papillomavirus infection, vaginal microecology, and cervical intraepithelial neoplasia in women from Xinjiang, China
by: Yi Shi, et al.
Published: (2024)

Detection of genes mutations in the K-ras, H-ras and EGFR in samples of blood plasma and cervical smears for patients with cervical intraepithelial neoplasia III and cervical cancer
by: Dabeiba Adriana García
Published: (2009)

Head‐to‐head comparison of the MyGen e human papillomavirus–sexually transmitted infection assay versus the Cobas 4800 human papillomavirus test for detecting high‐grade cervical intraepithelial neoplasia
by: Hang Zhou, et al.
Published: (2026)

Balancing diagnostic accuracy and cost in the follow‐up of histological low‐grade squamous intraepithelial lesions
by: Riina Aarnio, et al.
Published: (2026)

Effectiveness of prophylactic HPV vaccines against cervical abnormalities and HPV infection in Japan: The J‐HERS 2021 multicenter study
by: Yoshihiko Saeki, et al.
Published: (2024)

Long‐term outcomes of fertility‐sparing treatment in endometrial carcinoma and endometrial intraepithelial neoplasia: Recurrence risk factors over a 9‐year follow‐up
by: Ya‐Ting Hsu, et al.
Published: (2025)

Safety and adherence to self‐administered intravaginal 5‐fluorouracil cream following cervical intraepithelial neoplasia ( CIN ) 2/3 treatment among HIV ‐positive women in Kenya: A phase 1 clinical trial
by: Chemtai Mungo, et al.
Published: (2024)

Differentiated vulvar intraepithelial neoplasia long‐term follow up and prognostic factors: An analysis of a large historical cohort
by: Niccolò Gallio, et al.
Published: (2024)

Does HPV‐18 co‐infection increase the risk of cervical pathology in individuals with HPV‐16?
by: Mustafa Gökkaya, et al.
Published: (2024)

Cervical squamous and glandular intraepithelial neoplasia: identification and current management approaches
by: V. Cecil Wright
Published: (2003)

Human papillomavirus self‐sampling and urine‐sampling tests and the management and short‐term outcomes of cervical intraepithelial neoplasia: A prospective observational study
by: Motoki Matsuura, et al.
Published: (2024)

Similar Items

Similar Items